| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Verve Therapeutics, Inc. | Chief Scientific Officer | Restricted Stock Units | 0 | $68.1K | $5.64 | Jul 25, 2025 | Direct |
| Verve Therapeutics, Inc. | Chief Scientific Officer | Common Stock | 0 | $0 | $4.16 | Jul 25, 2025 | Direct |
| Verve Therapeutics, Inc. | Chief Scientific Officer | Stock Option (right to buy) | 0 | Jul 25, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| VERV | Verve Therapeutics, Inc. | Jul 25, 2025 | 7 | $0 | 4 | Jul 28, 2025 | Chief Scientific Officer |
| VERV | Verve Therapeutics, Inc. | Apr 1, 2025 | 4 | -$9.08K | 4 | Apr 3, 2025 | Chief Scientific Officer |
| VERV | Verve Therapeutics, Inc. | Jan 8, 2025 | 2 | $0 | 4 | Jan 10, 2025 | Chief Scientific Officer |
| VERV | Verve Therapeutics, Inc. | Jun 21, 2024 | 1 | $0 | 4 | Jun 25, 2024 | Chief Scientific Officer |
| VERV | Verve Therapeutics, Inc. | Jun 21, 2024 | 0 | $0 | 3 | Jun 25, 2024 | Chief Scientific Officer |